Based on comprehensive in vitro and in vivo studies we identify previously unknown LPA-RAGE axis and we show that, in non-small cell lung carcinomas (NSCLC) or A549 cells, LPA activates PKB and ERK pathways via RAGE. Here, AGER is linked to non-small cell lung carcinoma.